Everything behind my one-page profile: genomics, chemosensitivity, the CEA trajectory, every scan summary, every blood test since April 2025, the daily chemo log, my previous integrative protocol and the source files. Hard data only. If you just want the headlines, download the card.
Where things stand today: the baseline, what a cycle looks like, how the days have actually felt since chemo restarted, the tumour marker, the latest bloods and scan, and the files worth having.
As at 17 September 2026. Doses, bloods, letters and current medication are on Open Source Me.
Wed 16 Sep 2026 to Tue 29 Sep 2026. Cycle 4: Wed 30 Sep. New this cycle: metformin from day 4.
This is what I expect each day of a 14-day cycle to look like, built from my own tracking: how much energy I'll have, what movement is realistic, how much work I can do, when to rest and what to eat. Day 4 and 5 are the fatigue wall and the nadir. Days 10 to 13 are when I'm actually good. I rebuild this every couple of cycles.
EXPECTED ENERGY, MIDPOINT OF DAILY RANGE · ■ NADIR · ■ PEAK
| Day | Phase | Move | Work | Rest & sleep | Eat |
|---|---|---|---|---|---|
| Day 1Wed 16 | Infusion day5–7/10 | Hospital and a lot of sitting. Short local walk after discharge if I need to move. | 1 hr max, admin only. | Bed ~10 PM. 6–8 broken hours on steroids. | Break the 24-hour fast gently: broth, soft eggs, light soup. |
| Day 2Thu 17 | Steroid phase5–7/10 | Walk plus a short garden exercise session. No gym. | Up to 2 hrs at the desk, in short blocks. | Bed 10 PM. Nap 12–3 PM. Early waking likely. | Low-carb and soluble: soups, eggs, cooked greens, lean poultry. |
| Day 3Fri 18 | Steroid washout4–6/10 | Light walk and brief movement. Watch for sudden fatigue. | ~2 hrs, urgent tasks early. | Bed 9:30–10 PM. Horizontal 12–3 PM. 8+ hrs. | Ultra-gentle: warm soups, poached eggs, avocado, soft fish. |
| Day 4Sat 19 | The dip · fatigue wall2.5–4/10 | Cellular fatigue. Minimal movement, garden air only. | Zero work. Strict weekend boundary. | Bed 9–9:30 PM. Priority rest 12–3 PM. 9–10+ hrs. | Pureed and bland. Metformin starts, but only if eating normally. |
| Day 5Sun 20 | Peak nadir2–3.5/10 | Lowest capacity. Possible breathlessness on stairs. Complete pacing. | Zero work. No stressful comms or deep thinking. | Bed 9–9:30 PM. Afternoon sleep 12–3 PM. 9–10 hrs. | Light and warm, small frequent portions plus electrolytes. |
| Day 6Mon 21 | Gut transition3–5/10 | Slow stabilising. Light stroll as the cramps settle. | 1–2 hrs max, light admin. | Bed 9:30–10 PM. Lie-down 12–3 PM. | Clear soups, poached eggs, plain rice, cooked lean meat. |
| Day 7Tue 22 | Rebound boundary4–6/10 | Motility waking up. Light walking and stretching. | 1–2 hrs. Clear the backlog. | Bed 10 PM. 45-min lie-down. 8 hrs. | Solid whole foods again. Last Laxido day. |
| Day 8Wed 23 | Active rebound6–7/10 | Gym return: first session back, strength or Zone 1–2 bike. | 1–2 hrs. Good clarity for planning. | Bed 10 PM. Post-workout lie-down. 7.5–8 hrs. | Normal solids. Skin care on: the rash starts. |
| Day 9Thu 24 | Stamina rebuild6–7.5/10 | Strength training or outdoor exertion, 1–2 hrs. | 2–3 hrs. High clarity: client delivery, business ops. | Bed 10–10:30 PM. 7.5–8 hrs. | Full diet, high protein. Rash peak: creams on. |
| Day 10Fri 25 | Peak building7–8/10 | Structured cardio or strength. High capacity. | 2–3 hrs. Finish deep work before the weekend. | Bed 10:30 PM. Optional 20–30 min nap. | Full diet. Hydration and electrolytes. Keep moisturising. |
| Day 11Sat 26 | Peak performance7.5–9/10 | High stamina. Family outings, walks around Bath, DIY or gym. | Zero work. Normal weekend with Katy, Rex and Lyla. | Bed 10:30–11 PM. No nap needed. | Full and social. Keep alcohol minimal. |
| Day 12Sun 27 | Peak performance7.5–8.5/10 | Active family day, outdoors or DIY. | Zero work. | Bed 10 PM. Early wind-down. | Balanced whole food, high hydration. |
| Day 13Mon 28 | Pre-fast · peak output7–8/10 | Spin bike 20–30 min or active garden work. Final exertion day. | 3–5 hrs: peak output. Clear the backlog before infusion week. | Bed 9:30–10 PM. Deep restorative sleep. | Normal early day. Prep for the fast from midday Tuesday. |
| Day 14Tue 29 | 24-hour pre-chemo fast6.5–7.5/10 | Rest or gentle movement. No strain while fasting. | 3–5 hrs: prep and clear. | Bed 9:30 PM. Zopiclone if needed before the early hospital start. | 24-hour fast from midday: water, herbal tea, electrolytes. |
▾ Download the cycle map (PDF)
Mine, not a template. Doses and timings are set with my own team.
Every day since the first infusion on 19 August 2026, morning and evening: energy, mood, nausea, the cetuximab rash, and whether my bowels played ball. Scored morning and evening in my own words, then turned into numbers by the tracker. One day missing (28 Aug, a wedding).
I don't score myself out of ten any more. I say how I'm doing in my own words and the tracker makes the call, which stops me living in the same three numbers for months on end. This is the data the cycle map above is built from.
■ MORNING ENERGY · ■ EVENING ENERGY · ■ RASH · NAUSEA HAS BEEN 0 THROUGHOUT
| Date | Cycle | Energy AM | Energy PM | Mood AM | Mood PM | Nausea | Rash | Bowels |
|---|---|---|---|---|---|---|---|---|
| 20 Aug | C1 D2 | 6 | 5 | 6 | 7 | 0 | 1 | No |
| 21 Aug | C1 D3 | 7 | 4 | 6 | 6 | 0 | 0 | Yes |
| 22 Aug | C1 D4 | 7 | 4 | 6 | 3 | 0 | 0 | Yes |
| 23 Aug | C1 D5 | 4 | 3 | 6 | 5 | 0 | 0 | No |
| 24 Aug | C1 D6 | 5 | 4 | 3 | 3 | 0 | 0 | No |
| 25 Aug | C1 D7 | 5 | 4 | 6 | 6 | 1 | 1 | No |
| 26 Aug | C1 D8 | 7 | 5 | 7 | 6 | 0 | 3 | No |
| 27 Aug | C1 D9 | 5 | 6 | 6 | 7 | 0 | 2 | No |
| 29 Aug | C1 D11 | 7 | 7 | 8 | 8 | 0 | 4 | Yes |
| 30 Aug | C1 D12 | 7 | 5 | 8 | 8 | 0 | 3 | Yes |
| 31 Aug | C1 D13 | 8 | 5 | 7 | 7 | 0 | 2 | Yes |
| 01 Sep | C1 D14 | 7 | 6 | 8 | 8 | 0 | 2 | No |
| 02 Sep | C2 D1 | 7 | 4 | 7 | 6 | 0 | 1 | Yes |
| 03 Sep | C2 D2 | 6 | 4 | 7 | 7 | 0 | 0 | Yes |
| 04 Sep | C2 D3 | 4.5 | 5.5 | 6.5 | 7 | 0 | 0 | Yes |
| 05 Sep | C2 D4 | 3.5 | 2.5 | 5.5 | 4.5 | 2 | 0 | Yes |
| 06 Sep | C2 D5 | 3.5 | 2 | 3.5 | 3 | 3.5 | 0 | No |
| 07 Sep | C2 D6 | 3 | 5 | 2.5 | 7.5 | 4.5 | 0 | No |
| 08 Sep | C2 D7 | 3.5 | 4 | 4.5 | 6 | 3 | 0 | No |
| 09 Sep | C2 D8 | 5.5 | 7 | 0 | 0 | Yes | ||
| 10 Sep | C2 D9 | 6.5 | 6 | 7.5 | 8 | 0 | 1 | Yes |
| 11 Sep | C2 D10 | 7 | 6.5 | 8 | 8.5 | 0 | 2.5 | Yes |
| 12 Sep | C2 D11 | 8 | 7 | 8.5 | 8 | 0 | 3 | Yes |
| 13 Sep | C2 D12 | 8 | 6.5 | 8.5 | 8 | 0 | 2.5 | Yes |
| 14 Sep | C2 D13 | 8 | 7 | 8 | 8.5 | 0 | 2 | Yes |
| 15 Sep | C2 D14 | 7.5 | 6.5 | 8 | 8 | 0 | 1.5 | Yes |
CEA in ug/L. 19 readings from April 2025 to September 2026. Shaded bands are my three blocks of FOLFIRI + cetuximab. The normal range is roughly 0–5 (0–4.9 at the earlier lab, 0–5.2 at the current one).
Down from 85.4 to 11.4 through the first block in 2025. Up to 44.6 by November, alongside scans showing progression. Down to 15.8 through the spring 2026 block. Up again during the summer break, to 146 on 1 September, after the August scan showed progression. 50.9 on 14 September, two cycles into the restart.
| Date | CEA ug/L |
|---|---|
| 14 Sep 2026 | 50.9 |
| 01 Sep 2026 | 146 |
| 07 Aug 2026 | 87.6 |
| 23 Jul 2026 | 49.4 |
| 12 May 2026 | 15.8 |
| 20 Apr 2026 | 16.8 |
| 30 Mar 2026 | 21.1 |
| 16 Mar 2026 | 32.5 |
| 02 Mar 2026 | 38.6 |
| 06 Jan 2026 | 41.7 |
| 24 Nov 2025 | 44.6 |
| 07 Oct 2025 | 32.1 |
| 11 Aug 2025 | 15.6 |
| 30 Jun 2025 | 11.4 |
| 16 Jun 2025 | 17.5 |
| 02 Jun 2025 | 30.5 |
| 19 May 2025 | 68.2 |
| 01 May 2025 | 85.4 |
| 17 Apr 2025 | 66.1 |
Selected markers from blood reports since April 2025. Pink means above the reference range. Blue means below. A dot means not measured, or not yet in my records for that draw (23 Jul, 7 Aug and 1 Sep 2026 are CEA only for now). Source PDFs, redacted, are in the downloads section.
| Date | CEA ug/L |
Hgb g/L |
WBC 10⁹/L |
Neut 10⁹/L |
Lymph 10⁹/L |
Plt 10⁹/L |
ALP IU/L |
ALT IU/L |
AST IU/L |
Bili µmol/L |
Alb g/L |
Creat µmol/L |
CRP mg/L |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 Apr 2025 | 66.1 | 133 | 6.07 | 3.81 | 1.29 | 217 | 80 | 18 | 31 | 26 | 42 | 79 | · |
| 01 May 2025 | 85.4 | 135 | 5.97 | 3.16 | 1.80 | 256 | 113 | 53 | 34 | 10 | 43 | 75 | · |
| 06 May 2025 | · | 142 | · | 2.5 | 1.9 | 250 | · | · | · | · | · | · | · |
| 19 May 2025 | 68.2 | 140 | 7.29 | 4.45 | 1.94 | 267 | 138 | 50 | 33 | 19 | 44 | 79 | · |
| 02 Jun 2025 | 30.5 | 140 | 6.57 | 3.74 | 1.86 | 270 | 144 | 71 | 44 | 15 | 44 | 78 | · |
| 16 Jun 2025 | 17.5 | 136 | 5.34 | 3.00 | 1.58 | 298 | 145 | 47 | 32 | 18 | 43 | 75 | · |
| 30 Jun 2025 | 11.4 | 124 | 6.65 | 4.20 | 1.54 | 256 | 150 | 39 | 56 | 19 | 40 | 91 | 1 |
| 08 Jul 2025 | · | · | · | · | · | · | 211 | 42 | 31 | 14 | 43 | 70 | · |
| 11 Aug 2025 | 15.6 | 128 | 6.65 | 4.20 | 1.61 | 241 | 95 | 30 | 36 | 27 | 43 | 85 | · |
| 07 Oct 2025 | 32.1 | 131 | 6.43 | 4.02 | 1.31 | 277 | 90 | 16 | 27 | 9 | 43 | 94 | · |
| 24 Nov 2025 | 44.6 | 131 | 7.46 | 5.45 | 1.32 | 248 | 85 | 12 | 23 | 23 | 45 | 86 | · |
| 06 Jan 2026 | 41.7 | 129 | 8.85 | 5.81 | 1.65 | 232 | 77 | 16 | 26 | 18 | 42 | 75 | 87 |
| 02 Mar 2026 | 38.6 | 138 | 3.59 | 1.92 | 1.03 | 261 | 91 | 33 | 30 | 16 | 41 | 67 | · |
| 16 Mar 2026 | 32.5 | 142 | 7.21 | 4.30 | 2.29 | 249 | 122 | 29 | 25 | 10 | 43 | 68 | · |
| 30 Mar 2026 | 21.1 | 135 | 6.68 | 3.88 | 1.97 | 230 | 137 | 40 | 30 | 16 | 43 | 68 | · |
| 20 Apr 2026 | 16.8 | 129 | 4.33 | 2.28 | 1.30 | 255 | 99 | 30 | 33 | 39 | 41 | 69 | · |
| 05 May 2026 | · | 154 | 5.87 | 3.26 | 1.81 | 265 | · | · | · | · | · | · | · |
| 12 May 2026 | 15.8 | 126 | 24.18 | 19.83 | 2.64 | 305 | 187 | 38 | 33 | 10 | 43 | 63 | 1 |
| 23 Jul 2026 | 49.4 | 123 | · | · | · | · | 102 | · | · | · | 40 | · | · |
| 07 Aug 2026 | 87.6 | · | · | · | · | · | · | · | · | · | · | · | · |
| 01 Sep 2026 | 146.0 | · | · | · | · | · | 165 | · | · | · | · | · | · |
| 14 Sep 2026 | 50.9 | 133 | 6.64 | 3.99 | 1.70 | 289 | 179 | 26 | 26 | 13 | 43 | 75 | · |
A few things you'll notice. Liver enzymes (ALP / ALT) were elevated through the summer of 2025; ALP is above range again at 179 on 14 September 2026. CRP spiked to 87 in January 2026, the day of the scan that confirmed progression. White cells and neutrophils jumped on 12 May 2026 while CRP stayed at 1; worth knowing that pegfilgrastim (a white-cell booster) is given the day after each chemo, and dexamethasone for three days. Bilirubin was 39 on 20 April; I have Gilbert's syndrome. Globulin was 37 (range 19–35) on 14 September.
Myeloma markers. Smouldering myeloma under haematology surveillance. Last myeloma markers in my records: 30 Jun 2025, IgG kappa paraprotein, free kappa light chains 22.8 mg/L (range 3.3–19.4).
CT scans since July 2025, newest first. Quotes are the reporting radiologist's own words, condensed. Reports from July 2025 to January 2026 are in the downloads, with personal identifiers and clinicians' names redacted.
Next scan: after cycle 5 of the current block.
The four documents worth having if you're picking this up today. Older source files are in the archive below. Personal identifiers are redacted: NHS number, hospital numbers, address, and the names of clinicians and lab staff.
Sourced from Exacta / Astron data. These are the mutations driving the show.
Clarifications (September 2026 molecular summary).
MTOR was reported as "ICC positive amplification". Those are two different things. Immunocytochemistry shows protein expression; amplification needs copy-number testing. Unless a copy-number result turns up, this is MTOR pathway/protein positivity, not confirmed amplification, and it doesn't make me eligible for an mTOR inhibitor.
VEGFR1/VEGFR2 positivity suggests angiogenic signalling in the tumour microenvironment. It is not a validated biomarker for bevacizumab benefit.
HMGB1 overexpression is reported as 2.86-fold in the original slide deck and 2.55-fold in the September summary. I'm chasing the original report to settle which is right. Either way it's exploratory, not a treatment-selection biomarker.
TP53 p.R342* was labelled a missense alteration in one report. The asterisk means a premature stop codon, so it's a nonsense (stop-gain) variant.
PTEN is named as a variant in my oncology letters, but the exact variant, allele fraction and classification aren't in any report I hold. It's top of my list to chase.
An open record is only as good as what's in it. These are the documents that would make this genuinely complete for a molecular tumour board or a trial team, and that I'm chasing. If you're a clinician reading this and one of them is easy for you to release, you'd be doing me a favour.
By role. I don't publish my clinicians' names.
Still here, still public, just no longer the first thing you need. Open whichever section you want.
Every day for fourteen weeks, I logged what my body was doing. Mood, energy, nausea, rash, what I ate, what I drank, what I injected. I bolted a WHOOP onto my wrist and let it read the room when I couldn't. Bloods tell you what is in the blood. Scans tell you what the tumours look like. This tells you what living through chemo actually feels like on a Wednesday, and how often the Wednesdays are fine. The personal log was kept honest. Pints, pubs, melatonin, the lot.
Panel A: mood, energy, (10−nausea) and daily WHOOP recovery on a 0-100 scale. Panel B: HRV in ms (pink, left axis 0-50) and resting HR in bpm (cyan, right axis 50-90), with a faint 7-day rolling mean behind each line. Panel C: daily WHOOP day strain (0-21), coloured blue ≤ 10, yellow 10-14, pink ≥ 14. The pink band over 1-13 April marks the days the WHOOP was off. No data, not zero.
Drank a lot of beer and smoked a shisha on Saturday 18 April. Mood 10, energy 10, recovery 91. Sunday morning, recovery dropped to 8%. The single largest day-on-day WHOOP delta in the entire log. Other alcohol days follow the same shape, just less brutal.
Cinema food, pub pizza, big roasts, soy sauce, cheese. Same pattern, different vehicles. The log flags it four times across the three months. Imodium handles it; eating lighter prevents it.
There are days where WHOOP screams red and Russ logs a 9 or 10 for mood anyway. Subjective wellbeing and physiological recovery are two different signals. Both matter. Neither should be ignored.
Every cycle-start Tuesday shows the same shape. Resting heart rate climbs, HRV collapses, recovery drops below 60%. Subjectively, mood stays okay (8–9), but the body knows something has happened.
One row per cycle. Averages, extremes, GI days, alcohol days, the standout and the hardest day, plus what happened. Pink = the cost. Green = where I was holding up.
| Cycle | Dates | Avg Mood | Avg Energy |
Avg Nausea |
Avg Recovery | Low Recovery | High Recovery |
GI Days | Alcohol Days |
Standout / Hardest | Notable events |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cycle 1 Pre-FOLFIRI+Cet protocol |
17 Feb – 2 Mar 2026 13 days logged |
8.0 | 6.6 | 0.5 | 51.7% | 3% | 92% | 5 | 2 | ↑ 2026-02-20 (mood 8.0, recovery 92.0%) ↓ 2026-02-22 (mood 7.0, recovery 3.0%) |
Imodium first used (Day 4). Diarrhoea episodes triggered by roast dinner on Day 6. Day 12 was an alcohol day (96% Recovery despite). Cycle 1 first rash appearance Day 11. |
| Cycle 2 Pre-FOLFIRI+Cet protocol |
3 Mar – 16 Mar 2026 9 days logged |
8.8 | 6.9 | 0.0 | 46.6% | 8% | 81% | 1 | 1 | ↑ 2026-03-07 (recovery 81.0%) ↓ 2026-03-11 (mood 9.0, recovery 8.0%) |
Pump removed Day 3. Melatonin not yet in use. Diarrhoea triggered by fried/fatty cinema food. First sustained mood streak of 10/10s. |
| Cycle 3 Pre-FOLFIRI+Cet protocol |
17 Mar – 30 Mar 2026 13 days logged |
8.4 | 6.7 | 0.5 | 36.0% | 6% | 71% | 2 | 1 | ↑ 2026-03-27 (mood 10.0, recovery 71.0%) ↓ 2026-03-17 (mood 9.0, recovery 6.0%) |
Melatonin started Day 8 (after two nights of broken sleep). Temazepam used once. Skin temp running low. Apr 7 'exhausted all day' entry. |
| Cycle 4 Pre-FOLFIRI+Cet protocol |
31 Mar – 20 Apr 2026 (3 weeks) 7 days logged · 14 Apr infusion skipped |
8.9 | 6.9 | 0.4 | 61.0% | 61% | 61% | 0 | 0 | ↑ 2026-03-31 (mood 7.0, recovery 61.0%) ↓ 2026-03-31 (mood 7.0, recovery 61.0%) |
Shorter time on Whoop in early April (device unavailable approx 1 week). Apr 7 fatigue dip; then sustained mood/energy peak Apr 9-13. Cycle extended to 3 weeks: 14 Apr infusion was skipped, so 14-20 Apr is a treatment break inside Cycle 4. |
| Cycle 5 FOLFIRI + Cetuximab |
21 Apr – 4 May 2026 (after extra week off) 14 days logged |
7.9 | 6.3 | 2.1 | 47.2% | 7% | 93% | 1 | 1 | ↑ 2026-04-24 (mood 4.0, recovery 93.0%) ↓ 2026-04-28 (mood 8.0, recovery 7.0%) |
First cycle on FOLFIRI + Cetuximab. Bloods on 20 Apr (CEA 16.8). Apr 23 pump removal. May 1 socialising/5-pints day. Cycle ended with classic post-infusion crash. |
| Cycle 6 FOLFIRI + Cetuximab |
5 May 2026 – ongoing 6 days logged |
7.5 | 5.8 | 2.3 | 33.1% | 1% | 91% | 0 | 0 | ↑ 2026-05-05 (mood 10.0, recovery 91.0%) ↓ 2026-05-06 (mood 8.0, recovery 1.0%) |
Logging continues. May 8 was the worst day of the period (mood 3/10, stayed in bed). Constipation arc through the cycle. |
All seventy days. Click to expand. The 23 April entry has one phrase anonymised at the request of the family member named in the original; everything else is as logged.
Paused since August 2026. When chemo restarted, my oncologist advised suspending mistletoe and most supplements and off-label drugs. This is the protocol as it stood in June 2026, kept for the record. What I actually take now is on Open Source Me.
Issued 5 June 2026. Colorectal adenocarcinoma · FOLFIRI + Cetuximab (14-day cycle). Status then: OFF-CHEMO BREAK. What follows is the current daily baseline. The cycling rules and chemo-week rules further down activate when chemo restarts. This is rendered verbatim from the protocol document, dose for dose.
⚕️ Read this before anything below it. This is my personal regimen, agreed with my named prescribers. It is not medical advice and it is not a recipe to copy. Doses here are calibrated to one 85kg body, one genomic profile, one set of bloods, and one set of prescribers who monitor me. Some items carry real risk at these doses. If anything here is useful to you, take it to your own clinical team. Do not start, stop, or copy any of it on the strength of a web page.
▾ Download the full protocol (DOCX)
AM pot taken at breakfast. PM pot taken at the evening meal (it carries the fat-dependent drugs — Mebendazole, Fenbendazole, Vitamin D3, Ivermectin — which absorb poorly without dietary fat). A dash means the item is not in that pot.
| Drug | AM (breakfast) | PM (evening meal — fat) |
|---|---|---|
| Citalopram 30mg | 1 | — |
| Metformin 500mg | 1 | 1 |
| Mebendazole 100mg | — | 2–3 (fatty meal) |
| Doxycycline 100mg | 1 | — |
| Propranolol 20mg | 1 | 1 |
| Berberine 500mg | 1 | 1 (until stock runs out — do not reorder) |
| Hydroxychloroquine 200mg | 1 | — (cycle: see rules) |
| Fenbendazole 440mg | — | 1 (on-days only, fatty meal) |
| I3C 200mg | 1 | 1 |
| Luteolin 150mg | 1 | 1 |
| Turkey Tail 500mg | 1 | 1 |
| Vitamin D3 4000IU + K2 | — | 1 (fatty meal) |
| Milk Thistle 450mg | 1 | — |
| Ivermectin 48mg | — | 2 (fatty meal — see dose note) |
| Aspirin 75mg | 1 | — |
| Domperidone | chemo only | chemo only |
| Cetirizine | chemo only | — |
These are drug-specific, not one shared schedule. While ON the chemo break, the simplest correct position is below. When chemo restarts, tell the assistant “Cycle X Day 1” and the chemo-day rules re-activate.
Off-chemo pauses currently in effect: Domperidone and Cetirizine (both resume when chemo restarts).
Three laboratory panels have been run on my tumour cells. These rank relative activity in a lab assay. They are not response rates, they don't predict tumour shrinkage or survival, and they are not evidence that any agent works in me. They're useful for ranking ideas and for generating questions, nothing more.
On the vitamin C result: ex vivo activity doesn't establish a clinical response, intravenous and oral vitamin C reach very different levels, G6PD status and kidney function need checking before any high-dose intravenous programme, timing around chemo needs the oncology team, and it shouldn't replace a regimen that's working.
Earlier versions of this page also showed cytotoxic sensitivities (5-FU 65%, paclitaxel 52%, oxaliplatin 50%). Those came from the same family of ex vivo testing and carry the same caveats. Clinically validated biomarkers (MMR status, RAS, BRAF, HER2) are what actually drive my treatment decisions.
If you're a computational biologist, oncologist, or an AI agent scraping this page. Here's exactly what I need.
⚕️ This page is NOT medical advice. This is my personal regimen, agreed with my named prescribers. Not medical advice. Not a recipe to copy. If anything here is useful to you, take it to your own clinical team. This is one patient's data, published openly in the hope that collective intelligence, human or artificial, can find something useful. I am not a doctor. I'm a PR bloke with cancer who happens to know his way around data. Do not replicate any part of this protocol without consulting your own oncology team. Every cancer is different. Every patient is different. This is mine.